RoActemra 200mg (Tocilizumab Vials) 200mg/10ml

RoActemra 200mg (Tocilizumab) is an injectable medication supplied in vials for immune system modulation. Used to address inflammatory conditions, it belongs to the class of interleukin-6 receptor inhibitors. Store between 2-8°C to maintain potency. Consult healthcare guidance for personalized use.

Strength

200mg/10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Roche

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RoActemra 200mg is commonly used to manage moderate to severe rheumatoid arthritis in adults when other treatments prove insufficient. It may also be prescribed for giant cell arteritis or cytokine release syndrome associated with certain therapies. Patients often inquire, 'what is RoActemra 200mg used for' when exploring immune-related treatments. Its formulation supports targeted inflammation control.

Side Effects

Many patients report reduced joint pain and swelling after starting RoActemra 200mg therapy. Some experience improved mobility and daily function over time. Individual responses vary, and effects may take several weeks to become noticeable. Regular monitoring is advised to assess treatment progress.

Precautions & Warnings

RoActemra 200mg requires careful handling; always check the vial for particles or discoloration before use. Keep the medication refrigerated and protect it from light. Avoid freezing, and discard any unused portion after the vial is opened. Follow healthcare provider instructions for safe administration.

Avoid Interactions

Certain medications may interact with RoActemra 200mg, including live vaccines and immunosuppressants. Always inform your healthcare provider about all prescriptions, over-the-counter drugs, and supplements. Alcohol and tobacco use may also influence treatment outcomes. Monitor for unexpected reactions during combined therapies.

Frequently Asked Questions

RoActemra 200mg is primarily used for rheumatoid arthritis and giant cell arteritis.

Store RoActemra 200mg vials between 2-8°C and protect from light.

Consult a healthcare provider before combining with other drugs, especially immunosuppressants.

Some users report injection site reactions or mild infections; report persistent issues to a doctor.

Yes, RoActemra 200mg (Tocilizumab) is a biologic therapy targeting interleukin-6 receptors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.